Free Trial
NASDAQ:QIPT

Quipt Home Medical (QIPT) Stock Price, News & Analysis

Quipt Home Medical logo
$2.54 -0.06 (-2.31%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.54 +0.00 (+0.20%)
As of 02/21/2025 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Quipt Home Medical Stock (NASDAQ:QIPT)

Key Stats

Today's Range
$2.52
$2.64
50-Day Range
$2.41
$3.23
52-Week Range
$2.30
$4.58
Volume
118,891 shs
Average Volume
130,070 shs
Market Capitalization
$109.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.25
Consensus Rating
Buy

Company Overview

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Quipt Home Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

QIPT MarketRank™: 

Quipt Home Medical scored higher than 59% of companies evaluated by MarketBeat, and ranked 430th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Quipt Home Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Quipt Home Medical has received no research coverage in the past 90 days.

  • Read more about Quipt Home Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Quipt Home Medical are expected to decrease in the coming year, from ($0.05) to ($0.13) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Quipt Home Medical is -14.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Quipt Home Medical is -14.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Quipt Home Medical has a P/B Ratio of 1.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.89% of the float of Quipt Home Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Quipt Home Medical has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in Quipt Home Medical has recently decreased by 5.06%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Quipt Home Medical does not currently pay a dividend.

  • Dividend Growth

    Quipt Home Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.89% of the float of Quipt Home Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Quipt Home Medical has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in Quipt Home Medical has recently decreased by 5.06%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Quipt Home Medical has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Quipt Home Medical this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for QIPT on MarketBeat in the last 30 days. This is a decrease of -91% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Quipt Home Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $41,650.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    13.40% of the stock of Quipt Home Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.85% of the stock of Quipt Home Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Quipt Home Medical's insider trading history.
Receive QIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter.

QIPT Stock News Headlines

Reviewing Quipt Home Medical (NASDAQ:QIPT) & Mangoceuticals (NASDAQ:MGRX)
Watch This Robotics Demo Before March 17th
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Quipt Home Medical Corp. (QIPT): A Bull Case Theory
Stifel Canada Issues Optimistic Estimate for QIPT Earnings
Equities Analysts Offer Predictions for QIPT FY2026 Earnings
See More Headlines

QIPT Stock Analysis - Frequently Asked Questions

Quipt Home Medical's stock was trading at $3.05 at the start of the year. Since then, QIPT stock has decreased by 16.7% and is now trading at $2.54.
View the best growth stocks for 2025 here
.

Quipt Home Medical Corp. (NASDAQ:QIPT) issued its earnings results on Monday, February, 10th. The company reported ($0.03) earnings per share for the quarter. Quipt Home Medical had a negative trailing twelve-month return on equity of 6.70% and a negative net margin of 2.90%.

Top institutional investors of Quipt Home Medical include Claret Asset Management Corp (10.38%), Forager Capital Management LLC (9.75%), Royce & Associates LP (4.60%) and First Manhattan CO. LLC. (3.83%).
View institutional ownership trends
.

Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quipt Home Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

Last Earnings
2/10/2025
Today
2/22/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Healthcare
Current Symbol
NASDAQ:QIPT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.25
High Stock Price Target
$9.50
Low Stock Price Target
$2.50
Potential Upside/Downside
+146.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-6,760,000.00
Pretax Margin
-2.57%

Debt

Sales & Book Value

Annual Sales
$244.72 million
Cash Flow
$0.97 per share
Book Value
$2.47 per share

Miscellaneous

Free Float
37,317,000
Market Cap
$109.45 million
Optionable
Optionable
Beta
0.57
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:QIPT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners